| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |